TNONW · Tenon Medical, Inc.
Substantial doubt about the company's ability to continue as a going concern.
“There is substantial doubt about the Company's ability to continue as a going concern for one year after the date that these financial statements are issued.”View the 10-Q filed Aug 13, 2026
Price & Indicators
The closing range uses available history since Jul 23, 2026; less than a full year is stored.
Up next
Latest filings
On October 16, 2026, Tenon Medical, Inc. secured an investor waiver permitting an increase in its at-the-market offering and issued a Series B warrant for up to 125,000 shares at $5.02 per share, expiring September 14, 2031.
Read the 8-KQuarterly results
* Q4 derived as the full year minus Q1 to Q3.
Guidance & track record
Guidance from company 8-Ks · delivered figures from as-reported statements · no analyst estimates involved.
Technicals
trend & momentum for long-term holders illustrative — not investment adviceIllustrative technical + ownership context — a signal mix, not investment advice.
Key metrics
Earlier KPI extraction records exist, but do not meet the current evidence-completeness requirements. No current verified series is available. Earlier figures remain withheld until revalidated; this is not evidence that the company reports no KPIs.
Versus peers
Medical Devices — same industry group| Company | Mkt cap | YTD | Rev growth Y/Y | P/E | Short % shares |
|---|---|---|---|---|---|
|
TNONW
this stock
Tenon Medical, Inc.
|
$1.39M | — | +20.4% | — | — |
|
ABT
Abbott Laboratories
|
$184.98B | -15.2% | +5.7% | 34.4 | 1.0% |
|
MDT
Medtronic plc
|
$124.22B | +0.5% | +8.4% | 23.9 | 10.9% |
|
SYK
Stryker Corp
|
$113.52B | -17.0% | +11.2% | 31.8 | 1.5% |
|
BSX
Boston Scientific Corp
|
$60.84B | -56.0% | +12.5% | 17.0 | 2.8% |
Peers by industry group · P/E from as-reported trailing EPS · short % is of shares outstanding
At a glance
key data from every section- % held
- 1014.7%
- Reported
- 2 of 22
- Top holder
- Focus Partners Wealth
- Filed
- Oct 22, 2026
- This year
- 33
On October 16, 2026, Tenon Medical, Inc. secured an investor waiver permitting an increase in its at-the-market offering and issued a Series B warrant for up to 125,000 shares at $5.02 per share, expiring September 14, 2031.
ViewPerformance
| 5D | 20D | 120D | MTD | YTD | |
|---|---|---|---|---|---|
| TNONW | -46.4% | -50.0% | — | -50.0% | — |
| SPY | -0.6% | -1.8% | +2.2% | -0.9% | +10.8% |
| vs SPY | -45.9% | -48.2% | — | -49.1% | — |